Advisory · Hematology
Gene therapy and cell therapy are reshaping deal structures.
Ambrosia provides senior-led advisory for hematology licensing, M&A, and strategic partnerships — backed by a proprietary database of 125 verified hematology transactions.
Deal Landscape
What hematology transactions actually look like.
Verified Transactions
125
Median Upfront
$72M
Key Structure Insight
Gene/cell therapy hematology deals use fundamentally different milestone structures
Discuss your hematology transaction.
We’ll meet you at peer level — anywhere in the world.